Td Asset Management Inc Intellia Therapeutics, Inc. Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$23.16 - $32.34 $421,512 - $588,588	-18,200 Reduced 37.22%	30,692 $935,000
Q3 2023 Oct 27, 2023	BUY	$31.62 - $45.78 $772,982 - $1.12 Million	24,446 Added 100.0%	48,892 $1.55 Million
Q2 2023 Aug 09, 2023	SELL	$34.58 - $46.03 $184,138 - $245,109	-5,325 Reduced 17.89%	24,446 $996,000
Q1 2023 May 10, 2023	SELL	$33.3 - $44.82 $655,277 - $881,967	-19,678 Reduced 39.79%	29,771 $1.11 Million
Q4 2022 Feb 06, 2023	BUY	$33.21 - $62.69 $138,751 - $261,918	4,178 Added 9.23%	49,449 $1.73 Million
Q3 2022 Nov 07, 2022	BUY	$53.92 - $71.7 $21,244 - $28,249	394 Added 0.88%	45,271 $2.5 Million
Q2 2022 Aug 04, 2022	SELL	$38.49 - $76.21 $247,028 - $489,115	-6,418 Reduced 12.51%	44,877 $2.32 Million
Q1 2022 May 10, 2022	SELL	$58.27 - $118.99 $364,420 - $744,163	-6,254 Reduced 10.87%	51,295 $3.73 Million
Q4 2021 Feb 10, 2022	BUY	$100.76 - $138.36 $273,966 - $376,200	2,719 Added 4.96%	57,549 $6.81 Million
Q3 2021 Nov 09, 2021	SELL	$132.37 - $176.78 $145,607 - $194,458	-1,100 Reduced 1.97%	54,830 $7.36 Million
Q2 2021 Aug 11, 2021	BUY	$60.88 - $161.91 $270,976 - $720,661	4,451 Added 8.65%	55,930 $7.93 Million
Q1 2021 May 14, 2021	BUY	$46.59 - $83.68 $244,597 - $439,320	5,250 Added 11.36%	51,479 $4.13 Million
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $138,814 - $468,343	7,372 Added 18.97%	46,229 $2.52 Million
Q3 2020 Nov 10, 2020	BUY	$17.47 - $24.93 $75,121 - $107,199	4,300 Added 12.44%	38,857 $772,000
Q2 2020 Aug 13, 2020	BUY	$11.14 - $22.87 $384,964 - $790,318	34,557 New	34,557 $726,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$149 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$117 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$117 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$62.6 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$60.3 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account